News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 2508
- Sources here
- 12
- Companies here
- 25
Search results
Stored financial headlines
Active search
2508 matching headlines
Ticker or company: ANGMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Analysts’ Opinions Are Mixed on These Energy Stocks: North American Construction Group (NOA), Range Resources (RRC) and Williams Co (WMB)
Analysts have provided mixed opinions on three energy stocks: North American Construction Group (NOA), Range Resources (RRC), and Williams Co (WMB). North American Construction Group received "Hold" ratings from ATB Cormark Capital Markets and BMO Capital, with a moderate buy consensus. Range Resources also …
RRC
main company
Sharemaestro market context
Price above Trend Line
52 weeks +22.1% · Next-week setup positive 59.4%
Farallon group discloses 16.27M Tango Therapeutics (TNGX) shares and warrants
Farallon Capital Management, L.L.C. and its affiliated funds have disclosed a beneficial ownership of 16,270,187 shares of Tango Therapeutics (TNGX), representing 9.8% of the company's outstanding common stock. This includes 12,277,000 directly held shares and 3,993,187 pre-funded common stock purchase warrants, which are exercisable …
TNGX
main company
Sharemaestro market context
Trend signal active
52 weeks +271.0%
MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary
MANGOCEUTICALS, INC. reported Q2 2026 results with revenue of $68,757 and a net loss of $(1,606,653), translating to a diluted EPS of $(0.09). Revenue declined year-over-year by 59.1% as the company focused on strategic shifts towards telehealth platform growth and in-house e-commerce, but net …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
Mangoceuticals, Inc. announced its earnings for the second quarter and six months ending June 30, 2026. For the second quarter, sales were USD 0.068757 million with a net loss of USD 1.31 million. Over the six-month period, sales totaled USD 0.136621 million, resulting in …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Nuclea’s planned Moltex deal could add 80 nuclear patents
Mangoceuticals' merger partner, Nuclea Energy, Inc., has entered into a definitive agreement to acquire advanced nuclear technology assets from Moltex Energy, which is currently in administration. The acquisition includes intellectual property for Moltex’s SSR‑W advanced molten salt reactor, WATSS spent-fuel recycling process, and the …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
How New Debt Raise And Pershing Square Stake At Intercontinental Exchange (ICE) Has Changed Its Investment Story
Intercontinental Exchange (ICE) recently raised $3.73 billion in debt and saw new investment from Pershing Square, highlighting its position as a key global financial infrastructure. These developments, along with strong July trading volumes, reinforce ICE's near-term liquidity and trading activity, even as the company …
ICE
main company
Sharemaestro market context
Price above Trend Line
52 weeks -13.3%
Anghami Inc. (ANGH) details director resignation and new Audit Committee chair
Anghami Inc. (ANGH) reported the resignation of Michael Johnson from its board of directors, effective August 10, 2026. The company stated that his departure was not due to any disagreements regarding operations or policies. Following Johnson's resignation, Guergui Stoyanov was appointed to serve as …
ANGH
main company
Sharemaestro market context
Trend signal active
52 weeks +12.1% · Next-week setup negative 43.4%
Argus Adjusts Price Target on Intercontinental Exchange to $187 From $190, Keeps Buy Rating
Argus has adjusted its price target for Intercontinental Exchange (ICE) to $187 from $190, while maintaining a Buy rating on the stock. This news was published on August 14, 2026, at 05:59 AM EDT by MT Newswires. Intercontinental Exchange operates regulated futures exchanges and …
ICE
main company
Sharemaestro market context
Price above Trend Line
52 weeks -13.3%